PROficiency Based StePwise Endovascular Curricular Training: Multicentric Registry
Launched by UNIVERSITY HOSPITAL, GHENT · Nov 10, 2022
Trial Information
Current as of November 08, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "PROficiency Based StePwise Endovascular Curricular Training: Multicentric Registry," is designed to study how well surgical trainees learn and retain skills related to treating vascular diseases. The main focus is to see if the positive results of a previous study can be replicated in real-life situations, how well trainees keep their skills after finishing the program, and how effectively the training is applied in everyday medical practice.
To participate in this study, candidates must be surgical trainees who have completed specific assessments about their knowledge and skills. They will also need to complete a simulated exercise to practice what they’ve learned. This trial is currently recruiting participants and is open to individuals aged 65 to 74, regardless of gender. Those involved can expect to contribute to important research that could help improve training for future surgeons, ensuring they are well-prepared for real-life procedures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Surgical trainee
- • Knowledge and technical skill level evaluated
- • Demographics questionnaire and general MCQ test completed
- • Endovascular simulated exercise completed after familiarization with the simulator
- Exclusion Criteria:
- • N/A
About University Hospital, Ghent
University Hospital Ghent is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. Located in Ghent, Belgium, the hospital is affiliated with Ghent University, fostering a collaborative environment that integrates cutting-edge medical research with high-quality patient care. With a diverse range of specialized departments and a dedicated team of researchers and clinicians, University Hospital Ghent is at the forefront of developing new therapies and improving treatment protocols, aiming to enhance patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ghent, Belgium
Leuven, Belgium
Ghent, Oost Vlaanderen, Belgium
Copenhagen, Denmark
Patients applied
Trial Officials
Isabelle Van Herzeele, MD, PhD
Principal Investigator
University Hospital, Ghent
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials